Rapidnexus
1 known investors
Rapid Nexus Nanotech Wound Solutions develops a regenerative medical device technology (Hemastyl) that aims to repair nerves, muscle, and vasculature to heal chronic non-healing wounds and prevent amputations. It targets patients with diabetes, trauma, and peripheral vascular disease in the peripheral neuropathy and diabetic foot ulcer markets.
Founders & leadership
MK
Margaret KalmetaFounder & Chief Executive Officer
CP
Christine PasciakChief Operations Officer
MS
Malcolm St. JohnCFO